Genetic Testing on the Rise While Routine Lab Testing Stabilizes with Better Management, Report Finds
Lab test spending is challenged by a lack of control, pricing discrepancies and explosive growth in several tests…
Susan G. Komen® Unveils $26 Million Investment in Research Funding Focused on Metastatic Breast Cancer and New Treatments
Susan G. Komen®, the world’s leading breast cancer organization, today announced $26 million in funding for new research projects…